ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Mavenclad®:Merck (Schweiz) AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Zusammensetzung

Wirkstoffe
Cladribin.
Hilfsstoffe
Hydroxypropylbetadex (2-Hydroxypropyl-βcyclodextrin), Sorbitol (E420) 64.04 mg/Tablette, Magnesiumstearat.

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home